XORTX Therapeutics Inc.

NASDAQ: XRTX · Healthcare · Biotechnology

Canadian filerHQ Vancouver, BCCIK 0001729214Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 16

v0.1 · 5/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ workforce scale, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.3M

Employees

Market cap

$576.5k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$1.3M-1.7M CAD2021

Total assets$17.4M22.0M CAD2021

Liabilities$4.2M5.3M CAD2021

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

XORTX Therapeutics Inc. earned -$1.3M in FY2021 net income.

Peers · Healthcare

ENvue Medical, Inc.46D Neutra Corp.——SYBLEU Inc——Medical Marijuana, Inc.59C

Key facts

CEOAllen Warren Davidoff

SectorHealthcare

IndustryBiotechnology

HeadquartersVancouver, BC

ExchangeNASDAQ: XRTX

Employees2

IPO date2021-09-23

Latest filings

6-K2026-06-15 6-K2026-06-12 6-K2026-05-19 6-K2026-05-19 6-K2026-05-14 6-K2026-05-08 6-K2026-04-21 6-K2026-04-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.